Infinium Pharmachem Limited (NSE:INFINIUM)

India · Delayed Price · Currency is INR

266.20

-7.80 (-2.85%)

Sep 11, 2026, 3:18 PM IST

Infinium Pharmachem Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,896	1,896	1,557	1,357	1,142	991.19
Revenue Growth	20.95%	21.79%	14.78%	18.77%	15.24%	81.01%
Gross Profit	407.13	407.13	378.89	316.45	332.05	222.01
Operating Income	185.04	185.04	132.7	158.89	147.16	94.13
Net Income	121.5	121.5	81.45	113.02	94.9	61.06
Earnings Per Share	7.80	7.80	5.60	10.61	9.33	6.01
EPS Growth	28.52%	39.23%	-47.21%	13.64%	55.41%	124.55%

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Intermediate Chemicals	1,859	1,859	1,524	1,339	1,142	991.19
Biocall	31.23	31.23	33.25	18.06	-	-
Total	1,890	1,890	1,557	1,357	1,142	991.19

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	297.81	297.81	348.4	119.11	59.79	54.51
Total Debt	154.54	154.54	418.49	34.38	292.4	225.21
Net Cash (Debt)	143.27	143.27	-70.09	84.73	-232.6	-170.69
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	9.19	9.19	-4.82	7.95	-22.88	-16.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	337.34	337.34	-291.43	49.18	85.9	117.96
Capital Expenditures	-96.85	-96.85	-52.53	-35.12	-74.66	-47.27
Free Cash Flow	240.49	240.49	-343.96	14.06	11.23	70.69
Free Cash Flow Growth	-	-	-	25.14%	-84.11%	219.67%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	21.47%	21.47%	24.33%	23.33%	29.07%	22.40%
Operating Margin	9.76%	9.76%	8.52%	11.71%	12.88%	9.50%
Pretax Margin	9.41%	9.41%	7.43%	11.21%	11.34%	8.71%
Profit Margin	6.41%	6.41%	5.23%	8.33%	8.31%	6.16%
FCF Margin	12.68%	12.68%	-22.09%	1.04%	0.98%	7.13%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 12, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	34.14	24.73	41.33	28.20	-	-
P/FCF Ratio	17.25	12.49	-	226.68	-	-
PS Ratio	2.19	1.58	2.16	2.35	-	-